Inventor · disambiguated record
Andreas Haupt
Also filed as: HAUPT ANDREAS
70 granted patents·26 pending applications·837 citations·filing 1992–2019
99Inventor score
Top patents by PatentIndex Score
96 records- 0198US6323315B1Dolastatin peptidesBASF AG·Filed 2000·Granted Nov 27, 2001·309 cites·18 claims
- 0291US6143721ADolastatin 15 derivativesBASF AG·Filed 1997·Granted Nov 7, 2000·68 cites·39 claims
- 0390US8076326B2N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted Dec 13, 2011·23 cites·28 claims
- 0488US8440694B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2012·Granted May 14, 2013·12 cites·13 claims
- 0587US10118926B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 6, 2018·10 cites·6 claims
- 0687US6919342B2Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2004·Granted Jul 19, 2005·17 cites·15 claims
- 0785US6458765B1Dolastatin 15 derivativesBASF AG·Filed 2000·Granted Oct 1, 2002·15 cites·33 claims
- 0883US8183237B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted May 22, 2012·4 cites·17 claims
- 0982US5502032APeptides, the preparation and use thereofBASF AG·Filed 1994·Granted Mar 26, 1996·52 cites·13 claims
- 1080US8343959B2N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2011·Granted Jan 1, 2013·5 cites·10 claims
- 1180US7790727B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2008·Granted Sep 7, 2010·4 cites·31 claims
- 1280US6683055B1Low molecular weight inhibitors of complement proteasesBASF AG·Filed 2000·Granted Jan 27, 2004·17 cites·16 claims
- 1379US7368528B2Antineoplastic peptidesABBOTT GMBH & CO KG·Filed 2005·Granted May 6, 2008·2 cites·2 claims
- 1479US5965537ADolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminusBASF AG·Filed 1997·Granted Oct 12, 1999·37 cites·21 claims
- 1579US5741892APentapeptides as antitumor agentsBASF AG·Filed 1996·Granted Apr 21, 1998·50 cites·8 claims
- 1678US7807779B2Antineoplastic peptidesABBOTT GMBH & CO KG·Filed 2008·Granted Oct 5, 2010·2 cites·4 claims
- 1778US7084110B2Dolastatin 15 derivativesABBOTT GMBH & CO KG·Filed 2002·Granted Aug 1, 2006·7 cites·1 claims
- 1876US7851463B2Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Dec 14, 2010·2 cites·21 claims
- 1976US7320979B2N-[(piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2004·Granted Jan 22, 2008·7 cites·22 claims
- 2075US9169253B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 27, 2015·1 cites·23 claims
- 2175US8710059B2N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2011·Granted Apr 29, 2014·3 cites·20 claims
- 2275US5985837ADolastatin 15 derivativesBASF AG·Filed 1998·Granted Nov 16, 1999·34 cites·21 claims
- 2375US5831002AAntitumor peptidesBASF AG·Filed 1995·Granted Nov 3, 1998·42 cites·10 claims
- 2474US8921406B25-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptorsAMBERG WILHELM·Filed 2006·Granted Dec 30, 2014·1 cites·23 claims
- 2574US8242102B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Aug 14, 2012·2 cites·23 claims
- 2673US9573950B2Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulatorsABBVIE DEUTSCHLAND·Filed 2015·Granted Feb 21, 2017·2 cites·48 claims
- 2773US8969552B2Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2005·Granted Mar 3, 2015·2 cites·25 claims
- 2873US7960386B2Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Jun 14, 2011·1 cites·12 claims
- 2973US6632795B1Dolastatin-15 derivatives in combination with taxanesBASF AG·Filed 2000·Granted Oct 14, 2003·6 cites·22 claims
- 3072US8772313B2Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2011·Granted Jul 8, 2014·2 cites·21 claims
- 3172US8362010B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2010·Granted Jan 29, 2013·2 cites·23 claims
- 3271US8232426B2Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2005·Granted Jul 31, 2012·1 cites·19 claims
- 3368US9388148B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 12, 2016·1 cites·6 claims
- 3468US8507469B2Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorSCHULTZ THOMAS·Filed 2008·Granted Aug 13, 2013·2 cites·44 claims
- 3567US8008488B2Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligandsABBOTT GMBH & CO KG·Filed 2004·Granted Aug 30, 2011·3 cites·20 claims
- 3665US8163698B2Dolastatin 15 derivativesJANSSEN BERND·Filed 2009·Granted Apr 24, 2012·0 cites·16 claims
- 3765US8101754B2Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorUNGER LILIANE·Filed 2005·Granted Jan 24, 2012·1 cites·21 claims
- 3864US7465744B2Triazole compounds and the therapeutic use thereofABBOTT GMBH & CO KG·Filed 2004·Granted Dec 16, 2008·2 cites·16 claims
- 3964US2019048007A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 4063US6103698ADolastatin-15 derivatives in combination with taxanesBASF AG·Filed 1997·Granted Aug 15, 2000·18 cites·25 claims
- 4162US7723384B2Keto lactam compounds and use thereofABBOTT GMBH & CO KG·Filed 2004·Granted May 25, 2010·1 cites·19 claims
- 4262US7662786B2Dolastatin 15 derivativesABBOTT GMBH & CO KG·Filed 2006·Granted Feb 16, 2010·0 cites·12 claims
- 4361US2010210664A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorTURNER SEAN COLM·Filed 2008·Application pending·0 cites
- 4461US2015175570A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 4561US2015183770A15-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptorsABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 4659US2019135777A1Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptorABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 4759US2014200224A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorABBVIE DEUTSCHLAND·Filed 2013·Application pending·0 cites
- 4858US9994568B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2015·Granted Jun 12, 2018·0 cites·28 claims
- 4958US8293913B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Oct 23, 2012·0 cites·13 claims
- 5058US5886147ACompounds useful for the synthesis of dolastatin analogsBASF AG·Filed 1995·Granted Mar 23, 1999·9 cites·1 claims
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andreas Haupt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →